A multicomponent nanosystem for capturing circulating tumor cells from cancer patients with PD-L1 as an immunotherapy oncotarget
DOI:
10.1039/d4tb01360c
Publication Date:
2024-09-18T07:18:03Z
AUTHORS (15)
ABSTRACT
OncoDiscover® is a novel platform for the capture of rare circulating tumor cells from cancer patients in the presence of the PD-L1 oncotarget. It is being used routinely in the clinic for prognosis to improve the overall survival of cancer patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....